Since high antiproliferative activities were observed for compounds 2c, 2d, and 2g–i, these active compounds were docked into STAT3, which is a reasonable target of curcumin and structurally related compounds in pancreatic cancer [47,48]. This evidence concerns the gene STAT3 and pancreatic neoplasm.